Non-addictive, personalized treatments for chronic pain are urgently needed. Scientists are exploring the complex mechanisms of neuropathic, nociceptive, and inflammatory pain, but research has historically relied on animal models with limited clinical translation. Challenges related to species differences, ethical concerns, and patient to-patient variability highlight the need for robust, predictive in vitro assays to accelerate drug discovery. With the Maestro platform, scientists around the world are generating innovative stem cell models, evaluating personalized treatments, and identifying novel therapeutic targets.
Download the highlights and discover how the Maestro can aid in vitro pain research with these selected publications.